• Amitriptyline HCl: Practical Protocol Guide

  2026-09-03

  Amitriptyline HCl (SKU B2231) provides a defined salt-form small molecule for controlled studies of neurotransmitter receptor modulation, with dossier-reported purity, solubility, and receptor activity values that support assay planning. It is suitable for neuropharmacology research and carefully bounded mood disorder research or neurodegenerative disease model workflows, but it should not be treated as evidence of therapeutic efficacy or used with unvalidated long-term solution storage.

• SB 202190: p38 MAP Kinase Inhibitor Workflows

  2026-09-02

  SB 202190 enables controlled inhibition of p38α/β signaling in inflammation research, cancer therapeutics research, and regulated cell-death assays. This guide connects practical dosing and controls with RIPK1-focused experimental design, helping researchers distinguish p38 pathway effects from apoptosis or necroptosis mechanisms.

• Bardoxolone methyl: Redox Assay Workflows

  2026-09-02

  Build more interpretable oxidative stress and cancer assays with Bardoxolone methyl, also known as CDDO methyl ester. This guide connects KEAP1–Nrf2 activation and NF-kB inhibition with thioredoxin–RNR–CHK1 biology while providing practical dosing, controls, and troubleshooting strategies.

• Dabigatran Acylglucuronide Has Weaker Anticoagulant Activity

  2026-09-01

  The 2022 Pharmaceutics study directly compared dabigatran with its major active metabolite, dabigatran acylglucuronide, across thrombin-generation and routine coagulation assays. Although both compounds inhibited coagulation in a concentration-dependent manner, the metabolite required higher concentrations to produce comparable effects, an observation that informs interpretation of dabigatran exposure and assay data.

• 4-Ethylphenyl Sulfate: From Signal to Clearance

  2026-09-01

  4-Ethylphenyl sulfate is a microbiota-linked metabolite relevant to autism-spectrum and renal research. This article presents a clearance-aware framework that connects biomarker interpretation, behavioral studies, mass spectrometry, and cyclodextrin-based adsorption experiments.

• Perospirone: An Assay-First Pharmacology Guide

  2026-08-31

  Perospirone (SM-9018 free base) combines high-affinity serotonergic and dopaminergic receptor activity with a newly characterized vascular Kv-channel effect. This assay-first guide explains how to separate receptor pharmacology from off-target ion-channel responses in schizophrenia research and neurovascular models.

• Probenecid: An Assay-First Mechanistic Guide

  2026-08-30

  Probenecid, also known as 4-(dipropylsulfamoyl)benzoic acid, is best interpreted through an assay-first framework that separates transporter, pannexin-1, and neuroinflammatory effects. This guide connects those decisions to CD8+ T-cell metabolic flexibility while clearly defining the limits of current evidence.

• Dual-Readout mRNA for Translational Delivery

  2026-08-29

  A mechanistic framework for using dual fluorescence and bioluminescence reporters to separate mRNA delivery, intracellular trafficking, and productive translation in advanced therapeutic platforms.

• AhR–RBX1–HSF1 Signaling in Acute Pancreatitis

  2026-08-29

  Fang and colleagues identify an aryl hydrocarbon receptor–RBX1–HSF1 regulatory axis that links pancreatic acinar-cell stress responses with tight-junction preservation and macrophage polarization during acute pancreatitis. The study combines a severe cerulein/LPS model, primary acinar-cell experiments, database-guided interaction analysis, and pharmacological interference to provide a mechanistic framework for barrier protection.

• AM 281: CB1 Cannabinoid Receptor Antagonist Workflows

  2026-08-28

  AM 281 combines nanomolar CB1 affinity with a large CB2 selectivity gap, supporting receptor-binding, astrocyte–neuron mechanism, and traumatic brain injury assays. This practical workflow shows how to control solubility, bracket concentrations, and connect GLT-1, CREB, apoptosis, and cognition without overinterpreting an inverse agonist.

• Scalable EPSC-Derived MSC EVs: Study Analysis

  2026-08-28

  Gong et al. developed a bioreactor-based platform that generates extracellular vesicles from EPSC-derived mesenchymal stromal cells at substantially greater scale and with more standardized production than conventional primary MSC systems. In a bleomycin-induced pulmonary fibrosis model, these iMSC-EVs showed structural, molecular, and therapeutic characteristics comparable to primary MSC-EVs, supporting their potential for translational manufacturing.

• Estradiol Benzoate Assay Workflow Guide

  2026-08-27

  Build reproducible estrogen receptor alpha agonist experiments with practical stock-preparation, dosing, binding, reporter, and troubleshooting guidance. Estradiol Benzoate supports both quantitative receptor interaction studies and cell-based estrogen receptor signaling research when vehicle, timing, and orthogonal controls are managed carefully.

• Ceapin-A7 in Bone ER Stress Research

  2026-08-27

  Use Ceapin-A7 as a pathway-resolving probe to test whether ATF6α contributes to glucocorticoid-associated bone-cell stress, apoptosis, or impaired osteogenesis. This workflow complements the PTX3–TLR4/NF-κB/FGF21 model while keeping ATF6α inhibition experimentally distinct from broad ER-stress suppression.

• CCK8s, NOX4, and ANP Secretion in Rat Atria

  2026-08-26

  This study identifies a mechanistic pathway through which sulfated cholecystokinin octapeptide stimulates ANP secretion in isolated beating rat atria. Its experiments connect CCK receptor signaling to cPLA2-derived arachidonic acid, NOX4-generated H2O2, PGC-1α, and PPARα/PPARγ, while also indicating that ANP feeds back on oxidative-stress regulation.

• Gramine Targets CUL3–MTDH to Trigger TNBC Ferroptosis

  2026-08-26

  The reference study identifies Gramine as a selective inhibitor of triple-negative breast cancer models and links its activity to a previously underexplored CUL3–MTDH ubiquitination axis. By combining target-engagement assays, ferroptosis rescue experiments, genetic perturbation, and xenograft studies, the work provides a mechanistic framework for studying ferroptosis in TNBC.

452 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page